Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. 19 May 2020. Antony Koblish.

Executive Summary

TELA Bio, which makes hernia mesh that incorporates both sheep tissue and polymer fibers, has seen a jump in sales as concern about plastic mesh grows. Here’s company CEO Antony Koblish on how they successfully marketed OviTex products to all stakeholders.

“The value proposition must resonate for everybody. It must resonate for the patient [as] something safer and better. It must resonate for the surgeon – easy to use, great outcomes, versatile. And then it must resonate for the supply chain, understand the costs, and have a value proposition.” – Antony Koblish, CEO, TELA Bio

Click here for a free trial of Medtech Insight

Related Content

Topics

UsernamePublicRestriction

Register

MT143941

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel